| 摘要 |
A method for the manufacture of a medicament for immunity generation includes providing an anti-bacterial peptide, and causing the anti-bacterial peptide to react with a bacterium, virus, fungus, parasite or mycobacterium to produce a reaction product which can be delivered as an antigen complex via the chemotactic T-cell pathway to promote an adaptive immune system. The antibacterial peptide(s) are preferably sourced from insect tissues and/or larval forms. |
